The drugmaker had recently been in discussions to acquire RevMed in a deal that could have valued the cancer-drug biotech at around $30 billion.
Source link
Merck No Longer in Talks to Buy Revolution Medicines
Date:
More like thisRelated
EU unveils plan to help the bloc’s overlooked islands and coastal communities
PAPHOS, Cyprus -- Improving transportation links, ending energy isolation...
University of New Mexico law Dean faces both criticism and support over possible contract renewal
ALBUQUERQUE, N.M. (KRQE) – Several students, faculty, and alumni are calling...
Opinion | All of Gavin Newsom’s Donors
The Governor, his wife and California’s ‘behested payments.’
Source link...